AVXL
Price
$3.85
Change
+$0.09 (+2.39%)
Updated
May 3, 6:59 PM EST
5 days until earnings call
BEAM
Price
$23.13
Change
+$0.41 (+1.80%)
Updated
May 3, 6:59 PM EST
3 days until earnings call
Ad is loading...

AVXL vs BEAM ᐉ Comparison: Which is Better to Invest?

Header iconAVXL vs BEAM Comparison
Open Charts AVXL vs BEAMBanner chart's image
Anavex Life Sciences
Price$3.85
Change+$0.09 (+2.39%)
Volume$543.35K
CapitalizationN/A
Beam Therapeutics
Price$23.13
Change+$0.41 (+1.80%)
Volume$634.55K
CapitalizationN/A
View a ticker or compare two or three
AVXL vs BEAM Comparison Chart

Loading...

AVXLDaily Signal changed days agoGain/Loss if shorted
 
Show more...
BEAMDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
AVXL vs. BEAM commentary
May 04, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AVXL is a Hold and BEAM is a Hold.

COMPARISON
Comparison
May 04, 2024
Stock price -- (AVXL: $3.76 vs. BEAM: $22.72)
Brand notoriety: AVXL and BEAM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AVXL: 56% vs. BEAM: 71%
Market capitalization -- AVXL: $316.13M vs. BEAM: $1.9B
AVXL [@Biotechnology] is valued at $316.13M. BEAM’s [@Biotechnology] market capitalization is $1.9B. The market cap for tickers in the [@Biotechnology] industry ranges from $559.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.61B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AVXL’s FA Score shows that 1 FA rating(s) are green whileBEAM’s FA Score has 1 green FA rating(s).

  • AVXL’s FA Score: 1 green, 4 red.
  • BEAM’s FA Score: 1 green, 4 red.
According to our system of comparison, both AVXL and BEAM are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AVXL’s TA Score shows that 5 TA indicator(s) are bullish while BEAM’s TA Score has 4 bullish TA indicator(s).

  • AVXL’s TA Score: 5 bullish, 2 bearish.
  • BEAM’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, AVXL is a better buy in the short-term than BEAM.

Price Growth

AVXL (@Biotechnology) experienced а +10.91% price change this week, while BEAM (@Biotechnology) price change was +5.19% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +5.27%. For the same industry, the average monthly price growth was -0.50%, and the average quarterly price growth was +1243.13%.

Reported Earning Dates

AVXL is expected to report earnings on Aug 08, 2024.

BEAM is expected to report earnings on Aug 06, 2024.

Industries' Descriptions

@Biotechnology (+5.27% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for AVXL with price predictions.
OPEN
A.I.dvisor published
a Summary for BEAM with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
BEAM($1.9B) has a higher market cap than AVXL($316M). BEAM YTD gains are higher at: -16.532 vs. AVXL (-59.613).
AVXLBEAMAVXL / BEAM
Capitalization316M1.9B17%
EBITDAN/AN/A-
Gain YTD-59.613-16.532361%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
AVXL: Fundamental Ratings
AVXL
OUTLOOK RATING
1..100
3
VALUATION
overvalued / fair valued / undervalued
1..100
32
Undervalued
PROFIT vs RISK RATING
1..100
92
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
90
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AVXLBEAM
RSI
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
86%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
85%
N/A
Momentum
ODDS (%)
N/A
N/A
MACD
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
74%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
81%
Declines
ODDS (%)
Bearish Trend 9 days ago
79%
Bearish Trend 8 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
80%
Aroon
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
85%
View a ticker or compare two or three
Ad is loading...
AVXLDaily Signal changed days agoGain/Loss if shorted
 
Show more...
BEAMDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FIREX9.790.19
+1.98%
Fidelity Intl Real Estate
JACLX15.150.15
+1.00%
JHancock Mid Cap Growth C
FUFRX21.010.17
+0.82%
Franklin Utilities R6
PREOX16.780.12
+0.72%
Perritt Ultra MicroCap
HILGX11.790.07
+0.60%
Hennessy Cornerstone Large Growth Instl

AVXL and

Correlation & Price change

A.I.dvisor indicates that over the last year, AVXL has been loosely correlated with CORT. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if AVXL jumps, then CORT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AVXL
1D Price
Change %
AVXL100%
+1.90%
CORT - AVXL
52%
Loosely correlated
+4.94%
TENX - AVXL
47%
Loosely correlated
-2.82%
BEAM - AVXL
46%
Loosely correlated
+4.51%
AXON - AVXL
45%
Loosely correlated
+1.66%
NTLA - AVXL
44%
Loosely correlated
+3.42%
More

BEAM and

Correlation & Price change

A.I.dvisor indicates that over the last year, BEAM has been closely correlated with NTLA. These tickers have moved in lockstep 77% of the time. This A.I.-generated data suggests there is a high statistical probability that if BEAM jumps, then NTLA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BEAM
1D Price
Change %
BEAM100%
+4.51%
NTLA - BEAM
77%
Closely correlated
+3.42%
DNLI - BEAM
69%
Closely correlated
+4.02%
EDIT - BEAM
63%
Loosely correlated
+2.74%
PRME - BEAM
63%
Loosely correlated
+6.45%
VERV - BEAM
61%
Loosely correlated
+2.50%
More